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Antimicrobial peptides are part of the host defense sys-
tems of plants, insects, fish, amphibia, birds, and mam-
mals. These small proteins were previously thought of as
an evolutionarily ancient system of immune protection
with little relevance to the normal function of human
skin. Recent developments have found that mammalian
skin expresses these gene-encoded peptide antibiotics
during inflammatory events such as wound repair, contact
dermatitis, and psoriasis. The presence of these peptides
in the skin forms a barrier for innate host protection
against microbial pathogenesis. Furthermore, antimicro-
bial peptides also act on animal cells by stimulating
All multicellular organisms share the formidable task ofmaintaining a barrier against the physical and micro-biologic challenges of the environment. Given thischallenge, a system for efficient control of microbialproliferation must exist in mammalian skin. Such a
system would have two distinct functions. First, it would regulate the
colonization of the intact skin surface. Second, this defense system
would respond to disruption of epidermal integrity with an increase
in antimicrobial activity. In recognizing the importance of protecting
epithelial integrity, multicellular organisms respond to barrier com-
promise with a panoply of host defense mechanisms aimed at controlling
microbial proliferation.
Antimicrobial peptides, an integral component of the innate immune
system (Boman, 1995), have been discovered to function in the
response of mammalian skin to injury (Gallo et al, 1994; Harder et al,
1997; Stolzenberg et al, 1997). The innate immune system provides
broad-spectrum recognition and rapid elimination of invading micro-
organisms. This is distinct from the adaptive or clonal immune system
where a host response is initiated only following antigen stimulation
of specific lymphocyte subpopulations. Furthermore, recent evidence
demonstrates that elements of the innate immune system may regulate
the adaptive immune response through identification of microbial
proteins as foreign antigens and by activation of naı¨ve T cells (Fearon,
1997; Medzhitov et al, 1997). This function may be particularly
important when the microbial load threatens to overwhelm local
defenses and interfere with the wound repair process.
Components of the innate immune system are expressed constitu-
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them to change behaviors such as syndecan expression,
chemotaxis, and chloride secretion. The combination of
effects on host cells with antimicrobial action in a single
molecule represents an efficient defense and response
system against injury. Understanding the action of anti-
microbial peptides in skin may yield further insight into
the mechanism of innate cutaneous disease control and
provide new approaches to therapy of wounds and
inflammatory dermatitis. Key words: cathelicidins/contact
dermatitis/defensins/PR-39/wound repair. J Invest Dermatol
111:739–743, 1998
tively or are readily inducible. This is in contrast to the adaptive
immune system where mobilization, specificity, and immunologic
memory are developed over a period of days to weeks. Innate immunity
encompasses a variety of host defense modalities ranging in complexity
from simple inorganic molecules to cellular elements (Table I).
Although many of these are well characterized as to their role in
protection of the host organism, only recently has the diversity of
antimicrobial peptide structure and function been appreciated (Boman,
1995; Ganz and Weiss, 1997).
Antimicrobial peptides are expressed at high levels in organisms
including mammals, amphibians, insects, and plants (Boman, 1995).
The discovery of antimicrobial peptides in the mammalian epidermis
demonstrates a mechanism by which microbial growth can be controlled
in the first hours following epithelial injury, during the wound healing
process, and in the face of ongoing inflammation. Detailed investigations
of the biology of these peptides have demonstrated that in addition to
killing bacteria/viruses/fungi/protozoa, some of these peptides function
in regulating cell proliferation (Murphy et al, 1993), extracellular
matrix production (Gallo et al, 1994), and cellular immune responses
(Fleischmann et al, 1985; Huang et al, 1997). Thus, they provide a
powerful defense system that can both protect the skin from infection
and signal host cells to change their behavior in response to injury.
HISTORICAL BACKGROUND
Seminal work in the field of antimicrobial peptides was reported in
the early 1980s from the laboratory of Hans Boman (University of
Stockholm) (Steiner et al, 1981). He and colleagues injected bacteria
into pupae of the cecropia moth, and 7 d later purified newly
synthesized, 37 amino acid cationic peptides from the hemolymph.
These induced ‘‘cecropin’’ peptides demonstrated potent antibacterial
activity against Gram-negative bacteria including E. coli, B. subtilis, S.
marcescens, and P. aeruginosa.
The purification of insect cecropins was followed in the mid-1980s
by work from Robert Lehrer and his collaborators (UCLA), reporting
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Table I. Elements of innate immunitya
Type Examplesb
(1) Inorganic molecules HCl, nitric oxide, hydrogen peroxide
(2) Simple organic molecules Fatty acids
(3) Antimicrobial peptides Cecropins, magainins, defensins,
(, 100 a.a.) cathelicidins
(4) Antimicrobial proteins BPI, PLA2, lysozyme, complement
(5) Binding proteins Mannose binding protein, collectins
(6) Cytokines IL-10, IL-12, TNF-α
(7) Carbohydrates PGG-Glucan
(8) Cells Macrophages, neutrophils, natural killer cells
aSee the following reviews for further discussion: Boman et al, 1994; Boman, 1995;
Ganz and Weiss, 1997.
bBPI, bactericidal/permeability-increasing protein; PLA2, phospholipase A2.
the structures for an abundant class of peptides stored in specific
granules of rabbit and human granulocytes (Selsted et al, 1984, 1985).
These cationic, cysteine-rich ‘‘defensins’’ ranged in size from 29 to 34
amino acids and had a characteristic pattern of conserved amino acids,
including six cysteines involved in intramolecular disulfide bond
formation. They are bactericidal against both Gram-negative and
Gram-positive bacterial species and inactivate Cryptococcus neoformans
and Herpes simplex virus, Type 1.
In the late 1980s, a third milestone was the discovery by Michael
Zasloff (NIH) that Xenopus laevis skin contains multicellular glands rich
in cationic antimicrobial peptides (magainins) (Zasloff, 1987). Peptides
of the magainin family ranged in size from 23 to 27 amino acids with
apparently unrelated primary sequences. Their unifying feature is that
in hydrophobic environments they all assume amphipathic, α-helical
structures allowing them to insert into bacterial membranes and form
voltage-dependent ion channels (Soravia et al, 1988; Berkowitz et al,
1990). Magainin peptides alter the permeability of bacterial cells leading
to disruption of cytoplasmic processes and cell lysis (Boman, 1995).
In the 1990s there has been a rapid expansion in the field of
antimicrobial peptides with over 300 peptides reported (Table II). It
is now well established that an antimicrobial peptide response is a
common feature of defense systems in lower phyla. Surprisingly,
however, it has been recognized also that mammalian epithelial
structures are sites for the production of these peptides. Most recently,
mammalian skin (human, porcine, and bovine) has emerged as a source
for these molecules and is now a major point of emphasis.
DIVERSITY AND PROPERTIES OF ANTIMICROBIAL
PEPTIDES
The large number of antimicrobial peptides that have been purified or
predicted from nucleic acid analysis can best be understood from a
classification scheme based on peptide composition (Table III). The
peptides shown in Table III vary in structure and include amphipathic
α-helical peptides, bridged, disulfide-containing defensins, proline/
arginine-rich PR-39, and glutamic acid-containing anionic peptides.
The more that is known of the properties of specific antimicrobial
peptides, the more evident it becomes that few unifying principles can
be applied to the diverse peptide families; however, certain general
guidelines may aide in understanding the mechanisms for antimicrobial
peptide synthesis, storage, release, and activity.
Biosynthetic pathways Antimicrobial peptides are encoded in the
genome as prepropeptides, with a classical N-terminal signal peptide
targeting either intracellular storage or extracellular release (Bevins and
Zasloff, 1990; Ganz and Weiss, 1997). As most antimicrobial peptides
are membrane-active cationic molecules that can be toxic to intracellular
organelles (Westerhoff et al, 1989), during intracellular transport they are
maintained as inactive propeptides. The anionic pro segment functionally
neutralizes the cationic peptide, and may be responsible for intracellular
trafficking as well (Michaelson et al, 1992; Ganz et al, 1993; Liu and
Ganz, 1995).
One or more propeptides are encoded on a single translational
product, with multistep processing releasing the biologically active
peptide. Peptide storage sites include intracellular granules, as seen in
Table II. Select examples of known antimicrobial peptidesa
Insect peptides Mammalian peptides
Apidaecins Cathelicidins
Altacins Cecropins
Cecropins Defensins
Defensins Histatins
Diptericins Lactoferrins
Drosocins NK-lysin
Drosomycin Protegrins
Pyrrhocoricin
Sarcotoxins
Frog peptides Plant peptides
Bombinins Plant defensins
Brevinins
Caeruein precursor fragment
Magainins
aOver 300 distinct antimicrobial peptides have been identified in insects, animals, and
plants. This is a partial list of terms used to identify groups and individual peptides known
to have antimicrobial activity (reviewed in Bevins and Zasloff, 1990; Boman et al, 1994;
Cociancich et al, 1994; Boman, 1995; Zanetti et al, 1995; Ganz and Wiss, 1997).
mammalian granulocytes (Ganz et al, 1985; Lehrer et al, 1975), or large
glandular elements as seen in Xenopus skin and digestive tract (Zasloff,
1987; Reilly et al, 1994a, b). The peptide storage form may be the
active molecule or the inactive propeptide precursor. In the former
case, peptide activity may be neutralized by anionic components of
the granule basement membrane prior to release (Boman et al, 1994).
In the latter case, cellular activation leads to fusion of phagosomes with
both propeptide-containing granules and elastase-containing granules.
Elastase-mediated cleavage of the propeptide can then release the fully
functional antimicrobial agent (Zanetti et al, 1991).
Peptides stored in intracellular granules may function intracellularly
via fusion of granules with phagosomes containing ingested organisms.
Alternatively, neutrophils and macrophages attracted to sites of infec-
tion/injury may fuse their granule membrane with the cell membrane
leading to release of antimicrobial peptides into the local milieu.
Antimicrobial peptide synthesis, followed immediately by extra-
cellular release, represents a pathway common to inducible expression.
Exposure to live bacteria, heat killed bacteria, or simply epithelial
barrier compromise stimulate antimicrobial peptide synthesis (Dimarcq
et al, 1990; Kylsten et al, 1990; Diamond et al, 1996; Russell et al,
1996; Harder et al, 1997). Induction requires both RNA and protein
synthesis, is detectable within hours, and peaks between 16 h and
several days. Pathways for induction have been delineated in vitro in
bovine tracheal epithelial cells and in vivo in whole insects. In tracheal
epithelial cells, β-defensin induction has been shown to occur following
bacterial lipopolysaccharide binding to membrane protein CD-14 and
activation of the transcriptional regulator NF-κB (Diamond and Bevins,
1994; Diamond et al, 1996; Russell et al, 1996). In insects, there is a
homologous pathway involving the NF-κB related dif protein, as well
as additional pathways less well described (Dimarcq et al, 1990; Lemaitre
et al, 1995, 1997). From the insect studies there is evidence both for
generalized induction, in which expression of all antimicrobial peptide
gene families is upregulated, as well as specific induction that allows
for a more targeted response to a specific microbial infection.
Sites of synthesis A variety of tissues synthesize antimicrobial
peptides including bone marrow derivatives (granulocytes, macro-
phages), specialized epithelial cells (frog dermal glands, Paneth cells
of the small intestine, choroid plexus, vaginal epithelium), ciliated
epithelium (airway), and most recently keratinocytes (Diamond et al,
1993; Frohm et al, 1997; Ganz and Weiss, 1997; Harder et al, 1997).
Biochemical properties The majority of antimicrobial peptides are
enriched in arginine or lysine residues and are positively charged at
neutral pH (Boman, 1995; Ganz and Weiss, 1997). They are readily
soluble in water or saline and are resistant to heat denaturation.
Members of the defensin family are active in the presence of low salt
concentrations but inactive in high salt (Ganz and Weiss, 1997;
Goldman et al, 1997). In some cases sterospecific peptide activity has
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Table III. Structural classes of antimicrobial peptides
Class Examplea Structureb
(1) Linear, amphipathic α-helix LL-37 (Frohm et al, 1997) LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES
(2) Linear, enriched for select amino acid PR-39 (Agerberth et al, 1991) RRRPRPPYLPRPRPPPFFPPRLPPRIPPGFPPRFPPRFP
(3) Loop, single S-S bond Brevinin 2Ec (Boman, 1995) GILLDKLKNFAKTAGKGVLQSLLNTASCKLSGQC
(4) Multiple S-S bond, β-sheet Defensin TAP (Diamond et al, 1991) NPVSCVRNKGICVPIRCPGSMKQIGTCVGRAVKCCRKK
(5) Anionic, surfactant associated Sheep anionic peptides H-DDDDDDD-OH, H-GDDDDDD-OH, H-GADDDDD-OH
(Brogden et al, 1996)
(6) Fragment peptides Gastric Inhibitory Peptide (7–42) ISDYSIAMDKIRQQDFVNWLLAQKGKKSDWKHNITQ
(Agerberth et al, 1993)
(7) Large proteins BPI (Elsbach and Weiss, 1993) 455 a.a., cationic, 50–55-kDa
aBPI, bactericidal/permeability-increasing protein; TAP, tracheal antimicrobial peptide.
bLocation of disulfide bonds indicated by horizontal lines.
been demonstrated by comparing all D- and all L-enantiomers (Bessalle
et al, 1990; Wade et al, 1990; Vouldoukis et al, 1996). Given that in a
single tissue one may detect the simultaneous expression of multiple
antimicrobial peptides, it is not surprising to find that the individual
peptides display synergy with each other and with additional com-
ponents of innate immunity (Levy et al, 1994; Westerhoff et al, 1995).
ROLE OF ANTIMICROBIAL PEPTIDES IN THE SKIN
Two classes of antimicrobial peptides have been discovered in mamma-
lian skin: cathelicidins (Gallo et al, 1994; Frohm et al, 1997) and
β-defensins (Harder et al, 1997; Stolzenberg et al, 1997). A cathelicidin
was found first in skin during analysis of wound fluid components
(Gallo et al, 1994). Porcine wound fluid contains high levels of a
molecule that induces synthesis of syndecans-1 and -4, proteoglycans
involved in key aspects of wound repair. Purification and sequencing
of this molecule revealed a peptide identical to proline/arginine-rich
cathelicidin PR-39, an antimicrobial molecule previously identified in
pig gut and neutrophil azurophilic granules (Agerberth et al, 1991;
Storici and Zanetti, 1993).
The expression of a second cathelicidin, LL-37, was detected directly
in human skin keratinocytes but only where inflammation was present
(Frohm et al, 1997). LL-37 is expressed at involved sites of psoriasis,
nickel contact dermatitis, and systemic lupus erythematosus. The
absence of detectable LL-37 expression in uninflamed skin, assayed by
in situ hybridization and by reverse transcriptase-polymerase chain
reaction, suggests that this class of antimicrobial peptides functions
primarily in the response to injury rather than in modulating the
surface colonization of an intact epithelium.
A cysteine-rich β-defensin was discovered in human skin as the
result of direct investigation of antimicrobial activity present in psoriatic
scale. This peptide, given the designation human β-defensin-2 (hBD-
2), was purified based on its ability to bind E. coli (Harder et al,
1997). Peptide and cDNA sequencing demonstrated that hBD-2 is
homologous to β-defensins found in human urogenital tract, trachea,
and lung, as well as in mouse, cattle, and sheep tissues (Bensch et al,
1995; Zhao et al, 1996; Huttner et al, 1997, 1998; Stolzenberg et al,
1997). As in the case of LL-37, the expression of hBD-2 was
not detected in unstimulated keratinocytes but was inducible by
an exogenous stimulus. Cultured keratinocytes upregulated hBD-2
transcription in response to heat killed extracts of Gram– and Gram1
bacteria as well as Candida albicans (Harder et al, 1997). A similar
β-defensin response to inflammation is present in bovine skin
(Stolzenberg et al, 1997).
Analysis of human wound fluid constituents has identified additional
peptides with antimicrobial activity, including the human neutrophil
α-defensins HD1, HD2, and HD3, lysozyme, histone fragments, and
thymosin B-4 (Frohm et al, 1996). The cellular origin of many of
these factors is unclear, and they may represent products released by
tissue necrosis or recruited components of the wound repair process.
The variety and multiplicity of antimicrobial peptides supports the
likely function of innate immunity in mammalian skin.
MECHANISM OF ACTION
Recent studies of antimicrobial peptides have revealed unique mechan-
isms of action for this class of host defense agents. Although most
studies have emphasized their ability to kill microbes, they also have
direct actions on animal cells that may be of equal importance in the
host response to injury or infection.
Antimicrobial The mechanism of microbial killing by antimicrobial
peptides involves both their charge and their structure. The cationic
antimicrobial peptides interact with anionic components of bacterial,
viral, fungal, and protozoan lipid membranes (Kagan et al, 1994; Maloy
and Kari, 1995). This initial electrostatic attraction leads to membrane
insertion and/or penetration. Peptides with greater positive charge are
5–10 times more active against most bacteria (Lehrer et al, 1993). The
bactericidal properties of amphipathic, α-helical peptides (cecropins and
magainins), and disulfide-containing peptides (defensins) are thought to
relate to their ability to assemble in the target membrane and form a
pore (Fig 1A). The target organism is not able to compensate for the
presence of this pore, and energy and ion gradients are dissipated.
Bactericidal activity and cell lysis occur within minutes in proportion
to peptide concentration (Boman et al, 1993).
Antimicrobial peptide specificity for microbial membranes appears
to be determined both by the structure of anionic membrane com-
ponents and by the absence of cholesterol in prokaryotic cell membranes
(Tytler et al, 1995). Defensins but not magainins or cecropins require
cellular metabolic activity for membrane channel formation (Maloy
and Kari, 1995). Antimicrobial activity may be terminated either by
endoproteolytic cleavage of the peptide, demonstrated for the magainins
(Bessalle et al, 1990), or by protein binding in the case of defensin
inactivation (Panyutich and Ganz, 1991; Panyutich et al, 1995).
The proline/arginine (PR)-rich group of antimicrobial peptides has
proven to be an exception to the microbial killing mechanism described
for α-helical peptides (Boman et al, 1993). PR-rich peptides are
membrane active, but do not appear to form pores. Bacteria exposed
to these peptides first show a specific decrease in protein synthesis,
suggesting an alternative mechanism of action. Recent work suggests
that PR-rich peptides can bind intracellular targets in mammalian cells
(Fig 1B) (described below). A similar mechanism may explain the
inhibition of protein synthesis in bacteria.
Animal cells The peptide PR-39 was identified in wound fluid not
based on antimicrobial activity but rather on its activity as a syndecan-
inducer (synducin) (Gallo et al, 1994). Subsequent work has shown
that PR-39 has other effects on animal cells as well, including action
as a neutrophil chemoattractant (Huang et al, 1997). Defensins can act
as epithelial cell mitogens (Murphy et al, 1993) and induce chloride
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Figure 1. Models for antimicrobial peptide activity. (A) Antimicrobial
peptides such as defensins are thought to bind to microbial membranes based
on charge, and assemble to form a large pore. This illustration shows a prototype
amphipathic peptide interacting with a lipid bilayer. (B) Antimicrobial peptides
such as PR-39 do not appear to form a pore in membranes. This illustration
shows penetration of the linear peptide through a lipid bilayer and binding to
putative cytoplasmic receptor proteins.
secretion from cultured gut epithelial cells (Lencer et al, 1997). Other
peptides first discovered for their effects on physiologic processes, i.e.,
members of the calcitonin gene-related peptide superfamily (Vouldoukis
et al, 1996), have subsequently been found to have antimicrobial action.
Thus, in many cases the in vivo function for antimicrobial peptides
may be to act on cell behaviors in addition to microbial killing.
The mechanism(s) by which antimicrobial peptides influence animal
cell behavior are not clear; however, function likely relates to specific
structural considerations for each peptide. In the case of the PR-rich
peptides, their action appears to relate to the ability to bind cellular
proteins. PR-rich peptides penetrate fibroblast and endothelial cell
membranes and bind cytoplasmic proteins involved in integrin-medi-
ated cell signaling.1 PR-rich peptides also have been shown to bind
and affect the function of enzymes critical to neutrophil function (Shi
et al, 1996). In the case of the defensins, their action may relate to
function as an ionophore. For each class of antimicrobial peptides,
further investigation will be required to understand how and when
each acts on animal cells.
FUTURE DIRECTIONS
The vast array and diversity of antimicrobial peptides discovered in
lower phyla suggests that new molecules are likely to be found
in human skin. Several approaches are underway to identify new
antimicrobials in skin, including strategies based on sequence similarities
to known peptides and protein purification techniques based on
functional activity. As more components of the innate immune system
1Chan YR, Gallo RL: PR-39, a syndecan-inducing peptide secreted during
wound repair, binds intracellular SH3 targets. Molec Biol Cell 8, 1997 (abstr.)
are identified, it is possible that a fundamental restructuring of current
models of skin immunity will be in order.
In insects, cutaneous defense is characterized by the expression of
antimicrobial peptide genes within hours of cuticle damage or infection
(Dimarcq et al, 1990; Brey et al, 1993; Lemaitre et al, 1997; Ferrandon
et al, 1998). The discovery of antimicrobial peptides in human skin
now demonstrates the conserved role of innate immunity in epithelial
defense. Interestingly, the molecular regulatory elements of Drosophila
antimicrobial peptides are the transcripiton factors Dif and dorsal (Wu
and Anderson, 1998). These gene products are related to mammalian
NF-kB (Maniatis, 1997), a critical regulatory element both in innate
immunity [induces expression of β-defensins tracheal antimicrobial
peptide and LAP in bovine airway epithelial cells (Diamond et al,
1996; Russell et al, 1996)] and in adaptive immunity (modulates
lymphocyte differentiation) (Medzhitov et al, 1997). These parallels
demonstrate that in vertebrate evolution, pathways for induction of
innate immunity have been conserved as regulators of the adaptive
immune system. Hence, investigations into the biology of innate
immunity in mammalian skin may provide important evidence on the
coordinated control of epithelial adaptive immunity.
Our current model suggests that antimicrobial peptides are multifunc-
tional agents. First, by their ability to kill a variety of microbial
organisms these molecules likely present a barrier to inhibit infection.
In response to injury, keratinocytes rapidly increase synthesis of
antimicrobial peptides that participate with circulating cellular immune
elements in killing potential pathogens. Second, antimicrobial peptides
signal specific responses in the dermis and can modulate the activity
of circulating neutrophils. Together, these activities could represent a
critical component of skin biology. Future work will determine the
validity of such speculation and establish the utility of these peptides
in treatment of skin disease.
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